Troches & Buccal/Sublingual Testosterone
Compounded Oral-Mucosal Delivery and the Striant Precedent
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Striant (buccal system) was FDA-approved; many troches/sublingual forms are compounded (off-label)
- WADA
- Prohibited (S1 Anabolic Agent)
Reference only. Not medical advice.
What can go wrong
Buccal systems can cause gum and mouth irritation, altered taste, and require the product to stay adhered; troches can be swallowed or absorbed inconsistently, producing variable levels. Compounded troches are not standardized to the same degree as the discontinued/limited branded buccal systems, so titration relies on labs. As with any testosterone, systemic androgenic effects apply.
This is something to take to a clinician. The Atlas can tell you what is known about troches & buccal/sublingual testosterone in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Troches and buccal/sublingual testosterone dissolve against the cheek or under the tongue, absorbing through oral mucosa into the superior vena cava and bypassing first-pass liver metabolism. The FDA-approved precedent, Striant, was a 30 mg mucoadhesive buccal system applied twice daily that maintained physiological levels in trials. Today most mucosal testosterone is compounded as troches, valued for being needle-free and inexpensive, though absorption is variable and dosing is empirical.
Testosterone that absorbs through the cheek, skipping the liver.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
Venous drainage from the mouth flows to the superior vena cava rather than the Atlas vein, so testosterone absorbed across the buccal or sublingual mucosa enters systemic circulation directly, avoiding the extensive hepatic first-pass metabolism that makes plain oral testosterone impractical.
- Absorption surface
- Oral mucosa
- Striant time-above-range
- ~80% of 24-h period in study
- Compounded variability
- Higher; lab-confirm
Safety in detail
This intervention involves significant physiological effects and requires evaluation and monitoring by a qualified physician. Self-administration without medical oversight carries documented health risks. Compounded troche absorption is variable; dosing should be lab-confirmed.
Replacement is not the same as a cycle
Mucosal dosing targets physiological replacement; the studied branded system delivered near-physiological levels. Variable absorption from compounded troches can occasionally produce higher-than-intended exposure, reinforcing the need for lab confirmation rather than dose escalation by feel.
What it does to fertility
Buccal/sublingual testosterone is still exogenous testosterone and suppresses LH/FSH and intratesticular testosterone, impairing spermatogenesis; the mucosal route confers no fertility advantage.
What has to be monitored
The bloodwork this needs, and the reason it belongs with a clinician rather than a website.
- Total testosterone (timed to product kinetics)
- Estradiol
- Hematocrit/CBC
- PSA (age-appropriate)
- Oral/gum examination for irritation
What people get wrong
Often saidSwallowing a testosterone troche works fine
ActuallySwallowed testosterone is largely destroyed by first-pass liver metabolism; the mucosal route works only if it dissolves against the cheek or under the tongue and is absorbed there.
Often saidCompounded troches are as standardized as an FDA-approved product
ActuallyCompounded mucosal products vary in absorption and potency more than the studied branded buccal system; lab monitoring is needed to confirm levels.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
Set against the alternatives
Versus injections, mucosal delivery avoids needles and (with the branded system) gave steady physiological levels, but compounded troches show more variable absorption. Versus transdermal gels/creams, troches eliminate transference-by-skin-contact risk, though saliva and partner oral contact considerations differ.
At a glance
- Route
- Buccal (cheek) or sublingual (under tongue)
- FDA precedent
- Striant, 30 mg, twice daily
- Striant peak
- ~10-12 hrs after application (per study)
- Liver
- First-pass metabolism bypassed
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Troches & Buccal/Sublingual Testosterone. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
New testosterone buccal system (Striant) PK study in hypogonadal men2004
30 mg twice-daily buccal system maintained physiological testosterone for ~80% of a 24-hour period; PK largely unaffected by food, BMI, age